Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial Of 94 evaluable patients, 53% were ...
Non-Hodgkin’s lymphoma is a common type of blood cancer with several subtypes that require different treatments and have different outlooks. Non-Hodgkin’s lymphoma (NHL), sometimes just called ...
Recurrent Hodgkin lymphoma means the cancer returns after treatment and remission. In many cases, further treatments can help achieve remission or a possible cure. Hodgkin lymphoma (HL) is a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback